Did IBM beat expectations and raise its outlook for 2025?

Yes. Management said Q3 results exceeded its expectations for revenue, profitability, adjusted EBITDA, EPS and free cash flow. It raised full-year 2025 guidance for revenue growth (to more than 5% at constant currency), adjusted EBITDA growth (to mid-teens), operating pre-tax margin expansion (to over one point), and free cash flow (to about $14 billion).

What drove the strong growth in Q3 2025?

The main drivers were IBM Z, which grew 59% on the z17 launch, and Automation within Software, which grew 22% with contributions from HashiCorp. Red Hat bookings grew about 20%, and OpenShift ARR reached $1.8B. Consulting also returned to growth, and management credited productivity gains and portfolio mix for margin expansion.

Are there any weak spots in the results?

Transaction Processing revenue fell 3% as clients prioritized z17 hardware purchases, and Consulting total signings declined 5% year over year, although management said signing quality improved. Infrastructure Support was flat, and Strategy and Technology was flat. Management expects Transaction Processing to return to growth in Q4 based on its pipeline.

How is IBM's balance sheet and capital allocation trending?

Total debt rose to $63.1B at September 2025 from $55.0B at December 2024, with core non-financing debt at $51.8B. Year-to-date acquisitions totaled $7.9B, compared with $2.7B in the prior-year period. Cash and marketable securities were $14.9B, and dividends totaled $4.7B year to date. Management describes the balance sheet as solidly investment grade.

Is this 8-K a filed document, and what are the non-GAAP caveats?

Item 7.01 information, including Exhibits 99.1 and 99.2, is furnished rather than filed, so it is not subject to Section 18 liability. Key metrics such as constant-currency growth, adjusted EBITDA, operating EPS, and free cash flow are non-GAAP measures. Reconciliations to GAAP are included in the exhibits, and investors should review them, particularly where GAAP results include acquisition-related charges and one-time tax items such as the $0.3B H.R. 1 charge.

IBM 8-K: Regulation FD — Oct 23, 2025

01—Abstract

Summary

Summary of the 8-K filed October 23, 2025. Cited figures are marked; the original filing is the authoritative source.

IBM's third-quarter 2025 results, furnished under Item 7.01 of this 8-K on October 23, 2025, show accelerating momentum across the business.

Revenue rose 7% year over year at constant currency to $16.3 billion^a, the company's fastest growth in several years, with all three segments accelerating sequentially. Adjusted EBITDA grew 22% to $4.6 billion, adjusted EBITDA margin expanded 290 basis points, operating earnings per share rose 15% to $2.65, and free cash flow for the first nine months reached $7.2 billion, the highest year-to-date free cash flow margin in reported history. Segment performance was led by Infrastructure (up 15%, driven by IBM Z up 59% on the z17 launch) and Software (up 9%, with Automation up 22% and Red Hat bookings up about 20%).

Transaction Processing declined 3% as clients prioritized z17 hardware spend. Consulting returned to growth at 2%, though total signings fell 5%. Management cited about $4.5 billion^b of annualized productivity savings exiting 2025 and a GenAI book of business above $9.5 billion.

Management raised full-year 2025 guidance: revenue growth above 5% at constant currency, adjusted EBITDA growth in the mid-teens, operating pre-tax margin expansion of over one point, and free cash flow of about $14 billion^c. Investors should note that total debt rose to $63.1 billion, including $51.8 billion of core non-financing debt, up from $42.9 billion at year-end 2024, largely reflecting acquisition spending of $7.9 billion year to date, including HashiCorp.

02—Key points

Key Highlights

Q3 2025 revenue of $16.3B, up 7% at constant currency (9% as reported), the highest growth in several years, with all segments accelerating sequentially.
Adjusted EBITDA of $4.6B, up 22% year over year, with 290 bps of margin expansion; operating EPS of $2.65, up 15%.
Software revenue up 9% (Automation +22%, Data +7%, Hybrid Cloud +12%); Transaction Processing down 3%; OpenShift ARR reached $1.8B, growing over 30%.
Infrastructure revenue up 15%, with IBM Z up 59% on z17 strength; Consulting returned to growth at +2%, though signings declined 5%.
Full-year 2025 guidance raised: revenue growth above 5% (CC), adjusted EBITDA growth mid-teens, operating pre-tax margin expansion over 1 point, and free cash flow of about $14B.
Nine-month free cash flow of $7.2B, the highest year-to-date FCF margin in reported history; $4.7B returned to shareholders via dividends YTD.
Total debt increased to $63.1B (from $55.0B at December 2024) following $7.9B of YTD acquisitions, a point investors should weigh alongside cash of $14.9B.

03—Questions

Frequently Asked Questions

Did IBM beat expectations and raise its outlook for 2025?
Yes. Management said Q3 results exceeded its expectations for revenue, profitability, adjusted EBITDA, EPS and free cash flow. It raised full-year 2025 guidance for revenue growth (to more than 5% at constant currency), adjusted EBITDA growth (to mid-teens), operating pre-tax margin expansion (to over one point), and free cash flow (to about $14 billion).
What drove the strong growth in Q3 2025?
The main drivers were IBM Z, which grew 59% on the z17 launch, and Automation within Software, which grew 22% with contributions from HashiCorp. Red Hat bookings grew about 20%, and OpenShift ARR reached $1.8B. Consulting also returned to growth, and management credited productivity gains and portfolio mix for margin expansion.
Are there any weak spots in the results?
Transaction Processing revenue fell 3% as clients prioritized z17 hardware purchases, and Consulting total signings declined 5% year over year, although management said signing quality improved. Infrastructure Support was flat, and Strategy and Technology was flat. Management expects Transaction Processing to return to growth in Q4 based on its pipeline.
How is IBM's balance sheet and capital allocation trending?
Total debt rose to $63.1B at September 2025 from $55.0B at December 2024, with core non-financing debt at $51.8B. Year-to-date acquisitions totaled $7.9B, compared with $2.7B in the prior-year period. Cash and marketable securities were $14.9B, and dividends totaled $4.7B year to date. Management describes the balance sheet as solidly investment grade.
Is this 8-K a filed document, and what are the non-GAAP caveats?
Item 7.01 information, including Exhibits 99.1 and 99.2, is furnished rather than filed, so it is not subject to Section 18 liability. Key metrics such as constant-currency growth, adjusted EBITDA, operating EPS, and free cash flow are non-GAAP measures. Reconciliations to GAAP are included in the exhibits, and investors should review them, particularly where GAAP results include acquisition-related charges and one-time tax items such as the $0.3B H.R. 1 charge.

04—Continue

← View all 8-K filings